| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.3B | $23.3B | $23.5B | $20.9B | $19.3B | $17.0B | $19.8B | $21.1B |
| Cost of Revenue | $21.8B | $21.7B | $21.8B | $19.5B | $17.9B | $15.9B | $18.1B | $18.8B |
| Gross Profit | $1.5B | $1.6B | — | — | — | $0.5B | $0.3B | $0.5B |
| R&D Expense | — | — | — | — | — | — | $0.2B | $0.2B |
| SG&A Expense | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B | $0.6B |
| Operating Income | $0.8B | $0.9B | $0.9B | $0.7B | $0.7B | $0.5B | $1.1B | $1.7B |
| Net Income | $0.4B | $0.5B | $0.6B | $0.3B | $0.4B | $0.2B | $0.1B | $0.2B |
| EPS (Basic) | $8.22 | $9.02 | $9.73 | $5.49 | $6.22 | $3.35 | $2.51 | $3.42 |
| EPS (Diluted) | $8.15 | $8.97 | $9.68 | $5.47 | $6.19 | $3.33 | $2.50 | $3.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.8B | $14.0B | $14.7B | $13.8B | $13.4B | $13.2B | $12.7B | $11.6B |
| Current Assets | $7.7B | $7.2B | $7.6B | $7.0B | $6.8B | $6.8B | $6.4B | $6.3B |
| Cash & Equivalents | $1.0B | $1.1B | $1.2B | $1.1B | $1.3B | $1.3B | $1.5B | $1.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.7B | $5.4B | $5.7B | $5.2B | $4.8B | $5.1B | $4.7B | $4.5B |
| Stockholders' Equity | $5.0B | $4.5B | $4.9B | $4.7B | $4.6B | $4.5B | $4.3B | $4.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $1.2B | $1.0B | $0.7B | $0.7B | $1.3B | $1.8B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.8B | $-0.8B | $-0.6B | $-0.5B | $-0.9B | $-0.7B |
| Capital Expenditures | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.5B | $0.6B | $0.7B |
| Financing Cash Flow | $-0.6B | $-0.7B | $-0.4B | $-0.4B | $-0.0B | $-0.4B | $-0.4B | $-1.0B |